0

Liver Disease Collection
 61-80 of 979 Articles
Articles |  1 May 2007
Antibody to Hepatitis B Core Antigen and Risk for Hepatitis C–Related Hepatocellular Carcinoma: A Prospective Study
Kazuki Ikeda, MD; Hiroyuki Marusawa, MD, PhD; Yukio Osaki, MD; et al.
Ann Intern Med. 2007;146(9):649-656. doi:10.7326/0003-4819-146-9-200705010-00008
Medicine and Public Policy |  16 May 2006
A Framework for Management of Hepatitis C in Prisons
Anne C. Spaulding, MD, MPH; Cindy M. Weinbaum, MD, MPH; Daryl T.-Y. Lau, MD, MPH; et al.
Ann Intern Med. 2006;144(10):762-769. doi:10.7326/0003-4819-144-10-200605160-00010
Editorials |  16 May 2006
Hepatitis C: A Bitter Harvest
Jules L. Dienstag, MD
Ann Intern Med. 2006;144(10):770-771. doi:10.7326/0003-4819-144-10-200605160-00011
Articles |  21 March 2006 FREE
Brief Communication: Severe Hepatotoxicity of Telithromycin: Three Case Reports and Literature Review
Kimberly D. Clay, MD, MPH; John S. Hanson, MD; Scott D. Pope, PharmD; et al.
Ann Intern Med. 2006;144(6):415-420. doi:10.7326/0003-4819-144-6-200503210-00121
Editorials |  21 March 2006
Telithromycin
Michelle Turner, PharmD; G. Ralph Corey, MD; Elias Abrutyn, MD
Ann Intern Med. 2006;144(6):447-448. doi:10.7326/0003-4819-144-6-200603210-00014
Articles |  21 February 2006
Zoledronic Acid Prevents Bone Loss after Liver Transplantation: A Randomized, Double-Blind, Placebo-Controlled Trial
Bronwyn A.L. Crawford, MBBS, PhD; Cherie Kam, MPH, GDipScMed; Julie Pavlovic, RN; et al.
Ann Intern Med. 2006;144(4):239-248. doi:10.7326/0003-4819-144-4-200602210-00005
Articles |  17 January 2006
Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis
Eric F.H. van Bommel, MD, PhD; Tadek R. Hendriksz, MD; Antonius W.L.C. Huiskes, MD; et al.
Ann Intern Med. 2006;144(2):101-106. doi:10.7326/0003-4819-144-2-200601170-00007
Articles |  15 November 2005
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Masahide Hamaguchi, MD; Takao Kojima, MD; Noriyuki Takeda, MD; et al.
Ann Intern Med. 2005;143(10):722-728. doi:10.7326/0003-4819-143-10-200511150-00009
Editorials |  15 November 2005
Dangerous Liaisons: The Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Elizabeth E. Powell, MBBS, PhD; Julie R. Jonsson, BSc, PhD; Andrew D. Clouston, MBBS, PhD
Ann Intern Med. 2005;143(10):753-754. doi:10.7326/0003-4819-143-10-200511150-00015
Current Clinical Issues |  21 June 2005
Liver Cancer on the Rise
Jennifer Fisher Wilson
Ann Intern Med. 2005;142(12_Part_1):1029-1032. doi:10.7326/0003-4819-142-12_Part_1-200506210-00024
Articles |  17 May 2005
Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis
Fasiha Kanwal, MD, MSHS; Ian M. Gralnek, MD, MSHS; Paul Martin, MD; et al.
Ann Intern Med. 2005;142(10):821-831. doi:10.7326/0003-4819-142-10-200505170-00007
Reviews |  15 March 2005
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Karl E. Anderson, MD; Joseph R. Bloomer, MD; Herbert L. Bonkovsky, MD; et al.
Ann Intern Med. 2005;142(6):439-450. doi:10.7326/0003-4819-142-6-200503150-00010
Articles |  15 February 2005
A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
Henry Lik-Yuen Chan, MD; Nancy Wai-Yee Leung, MD; Alex Yui Hui, MB, BChir; et al.
Ann Intern Med. 2005;142(4):240-250. doi:10.7326/0003-4819-142-4-200502150-00006
Articles |  2 March 2004
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose
Stephanos J. Hadziyannis, MD; Hoel Sette, MD; Timothy R. Morgan, MD; et al.
Ann Intern Med. 2004;140(5):346-355. doi:10.7326/0003-4819-140-5-200403020-00010
Reviews |  2 March 2004
Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?
Stefan Zeuzem, MD
Ann Intern Med. 2004;140(5):370-381. doi:10.7326/0003-4819-140-8-200404200-00009
Articles |  18 November 2003 FREE
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
Hashem B. El-Serag, MD, MPH; Jessica A. Davila, PhD; Nancy J. Petersen, PhD; et al.
Ann Intern Med. 2003;139(10):817-823. doi:10.7326/0003-4819-139-10-200311180-00009
Reviews |  21 October 2003
Delayed Drug Hypersensitivity Reactions
Werner J. Pichler, MD
Ann Intern Med. 2003;139(8):683-693. doi:10.7326/0003-4819-139-8-200310210-00012
Brief Communications |  16 September 2003
Hepatic Injury in 12 Patients Taking the Herbal Weight Loss Aids Chaso or Onshido
Masayuki Adachi, MD; Hidetsugu Saito, MD, PhD; Hisashi Kobayashi, MD; et al.
Ann Intern Med. 2003;139(6):488-492. doi:10.7326/0003-4819-139-6-200309160-00012
Articles |  5 August 2003
The Effect of Selective Intestinal Decontamination on the Hyperdynamic Circulatory State in Cirrhosis: A Randomized Trial
Brindhesha Rasaratnam , MBBS, FRACP; David Kaye , MBBS, FRACP, PhD; Garry Jennings , MBBS, FRACP, MD; et al.
Ann Intern Med. 2003;139(3):186-193. doi:10.7326/0003-4819-139-3-200308050-00008
Reviews |  1 July 2003 FREE
Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C: A Systematic Review and Critical Analysis
Samir Gupta, MD; Stephen Bent, MD; Jeffrey Kohlwes, MD, MPH
Ann Intern Med. 2003;139(1):46-50. doi:10.7326/0003-4819-139-1-200307010-00012
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)